Page last updated: 2024-08-25

tocophersolan and Triple Negative Breast Neoplasms

tocophersolan has been researched along with Triple Negative Breast Neoplasms in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (25.00)24.3611
2020's3 (75.00)2.80

Authors

AuthorsStudies
Chen, X; Fang, K; Gao, X; Gong, J; Guo, D; Hu, S; Ji, H; Jiang, S; Lv, Y; Peng, L; Song, X; Yang, F; Zhang, J; Zhang, Y; Zuo, R1
Ahmad, FJ; Akhter, S; Garg, N; Kumar Jain, G; Selvapandiyan, A; Zafar, S1
Fang, K; Gao, X; Guo, D; Hu, S; Ji, C; Ji, H; Jiang, S; Li, G; Peng, L; Si, H; Song, X; Wang, J; Zhang, J; Zuo, R1
Chia, SL; Feng, SS; Kutty, RV; Leong, DT; Muthu, MS; Setyawati, MI1

Other Studies

4 other study(ies) available for tocophersolan and Triple Negative Breast Neoplasms

ArticleYear
Orally Administered Halofuginone-Loaded TPGS Polymeric Micelles Against Triple-Negative Breast Cancer: Enhanced Absorption and Efficacy with Reduced Toxicity and Metastasis.
    International journal of nanomedicine, 2022, Volume: 17

    Topics: Animals; Caco-2 Cells; Cell Line, Tumor; Humans; Mice; Mice, Nude; Micelles; Piperidines; Polymers; Quinazolinones; Triple Negative Breast Neoplasms; Vitamin E

2022
Co-encapsulation of docetaxel and thymoquinone in mPEG-DSPE-vitamin E TPGS-lipid nanocapsules for breast cancer therapy: Formulation optimization and implications on cellular and in vivo toxicity.
    European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V, 2020, Volume: 148

    Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Benzoquinones; Breast Neoplasms; Cell Line, Tumor; Cell Movement; Docetaxel; Drug Resistance, Neoplasm; Female; Humans; MCF-7 Cells; Mice; Mice, Inbred BALB C; Nanocapsules; Phosphatidylethanolamines; Polyethylene Glycols; Triple Negative Breast Neoplasms; Vitamin E

2020
Encapsulating Halofuginone Hydrobromide in TPGS Polymeric Micelles Enhances Efficacy Against Triple-Negative Breast Cancer Cells.
    International journal of nanomedicine, 2021, Volume: 16

    Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cell Survival; Drug Compounding; Female; Humans; Membrane Potential, Mitochondrial; Mice, Inbred BALB C; Mice, Nude; Micelles; Paclitaxel; Piperidines; Polymers; Quinazolinones; Reactive Oxygen Species; Treatment Outcome; Triple Negative Breast Neoplasms; Vitamin E

2021
In vivo and ex vivo proofs of concept that cetuximab conjugated vitamin E TPGS micelles increases efficacy of delivered docetaxel against triple negative breast cancer.
    Biomaterials, 2015, Volume: 63

    Topics: Animals; Antineoplastic Agents; Breast; Cell Line, Tumor; Cetuximab; Docetaxel; Drug Carriers; Drug Delivery Systems; Female; Humans; Mice, SCID; Micelles; Polyethylene Glycols; Taxoids; Triple Negative Breast Neoplasms; Vitamin E

2015